SEQUA Sequana Medical NV
0.6110EUR0.00%Mkt Cap: 51.92M $P/E: —3d ago
Sequana Medical NV develops and commercializes treatments for patients with diuretic-resistant fluid overload in liver disease, cancer, and heart failure in Belgium, Germany, France, and internationally. The company offe…
Industry Peers
Medical DevicesKey Statistics
Company
Market Cap51.92M USD
Enterprise Value75.05M USD
Revenue (TTM)0 USD
Gross Profit85.93K USD
Net Income (TTM)-48.54M USD
Revenue/Share0.00 EUR
Last Price0.6110 EUR
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees48
CountryBE
SectorHealthcare
IndustryMedical Devices
ISINBE0974340722
Valuation
P/E (Trailing)—
P/E (Forward)-1.67
PEG—
EV/EBITDA-4.01
EV/Revenue—
P/SInfinity
P/B-0.89
EPS (TTM)-1.23
EPS (Forward)-0.36
52W Range
0.460035% of range0.8870
52W High0.8870 EUR
52W Low0.4600 EUR
Profitability
Gross Margin74.94%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin-42325.70%
ROE100.62%
ROA-449.06%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-22.02M USD
CapEx (TTM)103.40K USD
FCF Margin—
FCF Yield-27.24%
Net Debt37.05M USD
Net Debt/EBITDA-1.98
Balance Sheet
Debt/Equity-0.90
Current Ratio0.20
Quick Ratio0.15
Book Value/Sh-0.69 EUR
Cash/Share0.13 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 EUR
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.78.17M
Float36.96M
Insiders9.59%
Institutions30.20%
Technical
SMA 500.6110 (+0.0%)
SMA 2000.5836 (+4.7%)
Beta-0.29
S&P 52W Chg14.58%
Avg Vol (30d)0
Avg Vol (10d)0
Technical Indicators
RSI (14)68.9
MACD0.0000
MACD Signal0.0000
MACD Hist.-0.0000
BB Upper0.6110 EUR
BB Middle0.6110 EUR
BB Lower0.6110 EUR
BB Width0.00%
ATR (14)0.0000 EUR
Vol Ratio (20d)—